Literature DB >> 16377387

CKD risk factors reported by primary care physicians: do guidelines make a difference?

Janice P Lea1, William M McClellan, Charlene Melcher, Elisa Gladstone, Tom Hostetter.   

Abstract

BACKGROUND: End-stage renal disease is epidemic within the United States among certain high-risk groups. The National Kidney Disease Education Program examined the awareness of chronic kidney disease (CKD) risk factors among primary care physicians who treat high-risk populations, such as African Americans, persons with diabetes, persons with hypertension, and family members of dialysis patients.
METHODS: We conducted a survey of 465 primary care physicians in 4 communities with high-risk populations. Respondents were asked to score 9 potential CKD risk factors on a 4-point scale graded from "Does not increase risk at all" to "Increases risk greatly." Potential risk factors included African-American race, diabetes, hypertension, and family history of CKD.
RESULTS: Respondents saw a mean of 414 +/- 222 (SD) patients/mo. Primary care physicians were more likely to report that diabetes and hypertension were significant risk factors for CKD. Conversely, 34.4% did not consider family history of kidney disease to increase the risk for CKD, and 22% of respondents did not consider African-American race a CKD risk factor.
CONCLUSION: Primary care physicians need targeted education to increase awareness of populations at high risk for CKD.

Entities:  

Mesh:

Year:  2006        PMID: 16377387     DOI: 10.1053/j.ajkd.2005.09.027

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  30 in total

1.  Primary care management of chronic kidney disease.

Authors:  Adrienne S Allen; John P Forman; E John Orav; David W Bates; Bradley M Denker; Thomas D Sequist
Journal:  J Gen Intern Med       Date:  2010-10-05       Impact factor: 5.128

2.  Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians.

Authors:  Raquel F Charles; Neil R Powe; Bernard G Jaar; Misty U Troll; Rulan S Parekh; L Ebony Boulware
Journal:  Am J Kidney Dis       Date:  2009-04-15       Impact factor: 8.860

3.  Awareness of chronic kidney disease among patients and providers.

Authors:  Laura C Plantinga; Delphine S Tuot; Neil R Powe
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

4.  User Requirements for a Chronic Kidney Disease Clinical Decision Support Tool to Promote Timely Referral.

Authors:  Joy Gulla; Pamela M Neri; David W Bates; Lipika Samal
Journal:  Int J Med Inform       Date:  2017-02-04       Impact factor: 4.046

5.  Diagnosis and management of mineral metabolism in CKD.

Authors:  Ishir Bhan; Anil Dubey; Myles Wolf
Journal:  J Gen Intern Med       Date:  2010-03-30       Impact factor: 5.128

6.  Chronic kidney disease identification in a high-risk urban population: does automated eGFR reporting make a difference?

Authors:  Laura C Plantinga; Delphine S Tuot; Vanessa Grubbs; Chi-yuan Hsu; Neil R Powe
Journal:  J Urban Health       Date:  2012-12       Impact factor: 3.671

7.  Population-based screening for CKD.

Authors:  Neil R Powe; L Ebony Boulware
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

8.  Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices.

Authors:  L Ebony Boulware; Kathryn A Carson; Misty U Troll; Neil R Powe; Lisa A Cooper
Journal:  J Gen Intern Med       Date:  2009-08-27       Impact factor: 5.128

9.  Recognition and management of chronic kidney disease in an elderly ambulatory population.

Authors:  Michael B Rothberg; Eileen D Kehoe; Abbie L Courtemanche; Thabo Kenosi; Penelope S Pekow; Maura J Brennan; Jeffrey G Mulhern; Gregory L Braden
Journal:  J Gen Intern Med       Date:  2008-04-29       Impact factor: 5.128

10.  Estimated GFR reporting is not sufficient to allow detection of chronic kidney disease in an Italian regional hospital.

Authors:  Giorgio Gentile; Maurizio Postorino; Raymond D Mooring; Luigi De Angelis; Valeria Maria Manfreda; Fabrizio Ruffini; Manuela Pioppo; Giuseppe Quintaliani
Journal:  BMC Nephrol       Date:  2009-09-01       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.